317 related articles for article (PubMed ID: 22479580)
1. Differences in nitrogen metabolism between Cryptococcus neoformans and C. gattii, the two etiologic agents of cryptococcosis.
Ngamskulrungroj P; Chang Y; Roh J; Kwon-Chung KJ
PLoS One; 2012; 7(3):e34258. PubMed ID: 22479580
[TBL] [Abstract][Full Text] [Related]
2. Nitrogen metabolite repression of metabolism and virulence in the human fungal pathogen Cryptococcus neoformans.
Lee IR; Chow EW; Morrow CA; Djordjevic JT; Fraser JA
Genetics; 2011 Jun; 188(2):309-23. PubMed ID: 21441208
[TBL] [Abstract][Full Text] [Related]
3. Factors Influencing the Nitrogen-Source Dependent Flucytosine Resistance in Cryptococcus Species.
Yang DH; Khanal Lamichhane A; Kwon-Chung KJ; Chang YC
mBio; 2023 Feb; 14(1):e0345122. PubMed ID: 36656038
[TBL] [Abstract][Full Text] [Related]
4. The GATA-type transcriptional activator Gat1 regulates nitrogen uptake and metabolism in the human pathogen Cryptococcus neoformans.
Kmetzsch L; Staats CC; Simon E; Fonseca FL; Oliveira DL; Joffe LS; Rodrigues J; Lourenço RF; Gomes SL; Nimrichter L; Rodrigues ML; Schrank A; Vainstein MH
Fungal Genet Biol; 2011 Feb; 48(2):192-9. PubMed ID: 20673806
[TBL] [Abstract][Full Text] [Related]
5. Differences between Cryptococcus neoformans and Cryptococcus gattii in the Molecular Mechanisms Governing Utilization of D-Amino Acids as the Sole Nitrogen Source.
Chang YC; Khanal Lamichhane A; Bradley J; Rodgers L; Ngamskulrungroj P; Kwon-Chung KJ
PLoS One; 2015; 10(7):e0131865. PubMed ID: 26132227
[TBL] [Abstract][Full Text] [Related]
6. Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing.
Klein KR; Hall L; Deml SM; Rysavy JM; Wohlfiel SL; Wengenack NL
J Clin Microbiol; 2009 Nov; 47(11):3669-72. PubMed ID: 19794048
[TBL] [Abstract][Full Text] [Related]
7. Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing.
McTaggart L; Richardson SE; Seah C; Hoang L; Fothergill A; Zhang SX
J Clin Microbiol; 2011 Jul; 49(7):2522-7. PubMed ID: 21593254
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
[TBL] [Abstract][Full Text] [Related]
9. Congenic strains for genetic analysis of virulence traits in Cryptococcus gattii.
Zhu P; Zhai B; Lin X; Idnurm A
Infect Immun; 2013 Jul; 81(7):2616-25. PubMed ID: 23670558
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an Nmr homolog that modulates GATA factor-mediated nitrogen metabolite repression in Cryptococcus neoformans.
Lee IR; Lim JW; Ormerod KL; Morrow CA; Fraser JA
PLoS One; 2012; 7(3):e32585. PubMed ID: 22470421
[TBL] [Abstract][Full Text] [Related]
11. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
12. Chitosan Biosynthesis and Virulence in the Human Fungal Pathogen Cryptococcus gattii.
Lam WC; Upadhya R; Specht CA; Ragsdale AE; Hole CR; Levitz SM; Lodge JK
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597720
[No Abstract] [Full Text] [Related]
13. Cryptococcus neoformans, Cryptococcus gattii: serotypes in Venezuela.
Pérez C; Dolande M; Moya M; Roselló A; de Capriles CR; Landaeta ME; Mata-Essayag S
Mycopathologia; 2008 Sep; 166(3):149-53. PubMed ID: 18512129
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
[TBL] [Abstract][Full Text] [Related]
15. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
[TBL] [Abstract][Full Text] [Related]
16. Population diversity and virulence characteristics of Cryptococcus neoformans/C. gattii species complexes isolated during the pre-HIV-pandemic era.
Pharkjaksu S; Kwon-Chung KJ; Bennett JE; Ngamskulrungroj P
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008651. PubMed ID: 33017391
[TBL] [Abstract][Full Text] [Related]
17. A Novel Role of Fungal Type I Myosin in Regulating Membrane Properties and Its Association with d-Amino Acid Utilization in Cryptococcus gattii.
Khanal Lamichhane A; Garraffo HM; Cai H; Walter PJ; Kwon-Chung KJ; Chang YC
mBio; 2019 Aug; 10(4):. PubMed ID: 31455652
[TBL] [Abstract][Full Text] [Related]
18. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
[TBL] [Abstract][Full Text] [Related]
19. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.
Basso LR; Gast CE; Bruzual I; Wong B
J Antimicrob Chemother; 2015 May; 70(5):1396-407. PubMed ID: 25630649
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
